Dosidal · Switzerland

GlucaGen Novo, Injektionspräparat

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:31489 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 31489
atc: H04AA01
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 1965-05-06
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: H04AA01
authorisation_number: 31489
form: PULP
holder: Novo Nordisk Pharma AG
holder_partner_nr: 1000306
it_number: 07.06.3.
name: GlucaGen Novo, Injektionspräparat
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
3l1_xxUPbnl2Q44XVZIR56p3ehSwMjh7s3D-SMIh4Aky2aBwGwYlt-5yozmLg-AEWNgd7fBm8Zy4OlgPpZjr-Q
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:31489 · Related records in other markets · Dosidal